News Releases Year None202120202019201820172016 January 20, 2021 Oncorus Announces Publication of Preclinical Data Demonstrating Potent Systemic Antitumor Activity of its Clinical Stage Oncolytic Herpes Simplex Viral Immunotherapy Product Candidate ONCR-177 January 4, 2021 Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
January 20, 2021 Oncorus Announces Publication of Preclinical Data Demonstrating Potent Systemic Antitumor Activity of its Clinical Stage Oncolytic Herpes Simplex Viral Immunotherapy Product Candidate ONCR-177
January 4, 2021 Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.